Susie X. Sun

1.0k citations
49 papers · 405 indexed · h-index 12
Topics
Breast Cancer Treatment Studies (31 papers)Breast Lesions and Carcinomas (16 papers)HER2/EGFR in Cancer Research (12 papers)

In The Last Decade

Susie X. Sun

41 papers receiving 398 citations

Peers

Susie X. Sun
Comparison fields: 5 of 66
  • Surgery 153
  • Cancer Research 131
  • Oncology 125
  • Public Health, Environmental and Occupational Health 75
  • Pulmonary and Respiratory Medicine 65
Replace Apoorve Nayyar with:
Apoorve Nayyar United States
Andrea L. Merrill United States
Meghan R. Flanagan United States
Raymond Oliphant United Kingdom
Sarah P. Shubeck United States
Cory A. Roberts United States
Lindsey M. Charo United States
Katherine Bingmer United States
Martin P. Morris United States
Νικόλαος Παραράς Greece
Susie X. Sun relative to Apoorve Nayyar United States Apoorve Nayyar's profile →
Citations per field
00.5×
Apoorve Nayyar · 1×
Citations per year

Countries citing papers authored by Susie X. Sun

Since Specialization
Citations

This map shows the geographic impact of Susie X. Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susie X. Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susie X. Sun more than expected).

Fields of papers citing papers by Susie X. Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susie X. Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susie X. Sun. The network helps show where Susie X. Sun may publish in the future.

Co-authorship network of co-authors of Susie X. Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Susie X. Sun. A scholar is included among the top collaborators of Susie X. Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susie X. Sun. Susie X. Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 2
4 4
5 1
6 0
7 4
8 5
9 4
10 8
11 5
12 1
13 1
14 6
15 11
16 0
17 4
18 9
19 21
20 18

About Susie X. Sun

Susie X. Sun is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 49 papers that have together received 405 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), Breast Lesions and Carcinomas (16 papers) and HER2/EGFR in Cancer Research (12 papers). The work is most often cited by research in Cancer Research (131 citations), Gender Studies (52 citations) and Oncology (125 citations). Susie X. Sun has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Christopher S. Hollenbeak, Afif N. Kulaylat, Henry M. Kuerer, Peter W. Dillon, Mediget Teshome, Wei Yang, Tanya W. Moseley, Anthony Lucci, Anna M. Leung and Joyce Wong. Their work appears in journals such as Cancer, Cancer Research and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026